Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer
Jin-Lai Wei1, Min Fang2, Zhong-Xue Fu1
1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Abstract:
Sestrin 2 is a conserved antioxidant protein that reduces reactive oxygen species (ROS) and inhibits mammalian target of rapamycin complex 1 (mTORC1). We previously showed that sestrin 2 is abnormally decreased in colorectal cancer (CRC). To elucidate the molecular mechanism behind the potential contribution of sestrin 2 to CRC, we used a lentiviral expression vector system to determine the effects of sestrin 2 overexpression on human CRC cells. We found that sestrin 2 overexpression decreased ROS production, inhibited cell growth, and stimulated apoptosis in two CRC cell lines. In parallel, expression of the proliferation marker PCNA was decreased, proapoptotic caspase 3, 7, and 9 levels were increased, and expression of the anti-apoptotic protein survivin was reduced. Sestrin 2 overexpression also activated the adenosine monophosphate-activated protein kinase (AMPK) pathway, and suppressed mTORC1 signaling. Treating CRC cells with compound C, an AMPK inhibitor, reversed or attenuated changes in proliferation, apoptosis, and signaling proteins of the AMPK/mTORC1 axis. In a xenograft mouse model, CRC growth was attenuated by sestrin 2 overexpression. These results suggest that sestrin 2 suppresses CRC cell growth through activation of the AMPK/mTORC1 pathway and induction of apoptosis, and could be a novel pharmacological target for the treatment of CRC.
Insights
Sestrin 2, an antioxidant protein, suppresses colorectal cancer (CRC) growth by reducing reactive oxygen species (ROS) and activating the AMPK/mTORC1 pathway. Overexpression of sestrin 2 inhibits CRC cell proliferation and promotes apoptosis, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sestrin 2 is an antioxidant protein known to reduce reactive oxygen species (ROS) and inhibit mammalian target of rapamycin complex 1 (mTORC1).
- Previous studies indicated that sestrin 2 levels are abnormally decreased in colorectal cancer (CRC).
Purpose of the Study:
- To investigate the molecular mechanisms by which sestrin 2 influences colorectal cancer progression.
- To determine the effects of sestrin 2 overexpression on human CRC cell lines and a xenograft mouse model.
Main Methods:
- Utilized a lentiviral expression vector system for sestrin 2 overexpression in human CRC cells.
- Assessed changes in ROS production, cell proliferation (PCNA), apoptosis (caspases, survivin), and signaling pathways (AMPK, mTORC1).
- Employed compound C (AMPK inhibitor) and a xenograft mouse model to validate findings.
Main Results:
- Sestrin 2 overexpression decreased ROS production, inhibited CRC cell growth, and stimulated apoptosis.
- Increased levels of proapoptotic proteins (caspase 3, 7, 9) and decreased levels of anti-apoptotic protein survivin were observed.
- Sestrin 2 activated the AMPK pathway, suppressed mTORC1 signaling, and attenuated CRC growth in vivo.
Conclusions:
- Sestrin 2 suppresses colorectal cancer growth via AMPK/mTORC1 pathway activation and apoptosis induction.
- Sestrin 2 represents a potential novel pharmacological target for CRC treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


